Healthcare -
Biotechnology - NASDAQ - US
$ 1.277
-5.41 %
$ 148 M
Market Cap
-14.19
P/E
CHRS - ACCOUNTS PAYABLE
Accounts Payable CHRS - Coherus BioSciences, Inc.
35.2 M
LAST VALUE
47.63%
2 YEAR CAGR
18.15%
5 YEAR CAGR
25.32%
10 YEAR CAGR